Establishment Labs
Rosalyn d’Incelli has been a part of Establishment Labs® since May of 2020 as the company’s Head of Clinical and Medical Affairs, bringing to the company over 20 years of medical device experience. In this role, she drives global clinical and medical strategy and execution and leads U.S. Regulatory Affairs. Prior to joining us, she was with Sientra Inc., for 11 years as the Vice President of Clinical and Medical Affairs. She was responsible for U.S. PMA approval, Medical Education, PR, Publications, and the company’s scientific content. She represented the company with FDA, media, and medical education events and congresses. Preceding to Sientra, Ms. d’Incelli held similar roles with PMA approvals at Mentor/Johnson & Johnson and Inamed (now Allergan/AbbVie). She holds a B.A. in communication/market research from the University of California, Santa Barbara, and is board certified in SoCRA and RAP.
This person is not in any offices
Establishment Labs
1 followers
Establishment Labs® (NASDAQ:ESTA) is a global medical technology company focused on improving patient safety and aesthetic outcomes, initially in the breast aesthetics and reconstruction market by designing, developing, manufacturing and marketing an innovative portfolio of silicone gel-filled breast implants, branded as Motiva Implants®, the centerpiece of the MotivaImagine® platform.